Global Phase I START operates a global network for Phase I anticancer trials across the United States, Europe, and Asia, presenting opportunities to partner on early-stage trial sites or patient recruitment programs in multiple regions.

Small to Medium With 11-50 employees and a focused clinical trial expertise, START is a niche partner for sponsors seeking agility, rapid site activation, and dedicated patient-access programs in underserved markets.

Cancer Focus The company specializes in anticancer drugs, aligning with potential collaborations in oncology drug development, early safety data generation, and translational research partnerships.

Strategic Access Locations in San Antonio, Madrid, and Shanghai offer regional access to diverse patient populations and regulatory environments, enabling sponsors to diversify trials and accelerate enrollment timelines.

Tech & Reach Established digital footprint and clinical trial operations capability by leveraging familiar tech stack and analytics tools, suggesting opportunities for joint data-sharing initiatives, site optimization, and digital patient engagement strategies.